deals

Deals (w/e 11/14/25)

Lee McCabe

15 Nov 2025 — 1 min read

Arcline Investment Management Acquires Novaria Group in ~$2.2 Billion Deal

Arcline is buying Novaria Group from KKR in an all-cash transaction valued at roughly $2.2 billion. Novaria, the Texas-based aerospace and defense components supplier, has been one of KKR’s industrial roll-up winners—13 acquisitions, tripled revenue, and deep entrenchment with Boeing, Airbus, and Tier-1 suppliers. Arcline is stepping into a platform with momentum and messiness: aerospace supply chains are recovering, but stitching together dozens of precision manufacturers is never a smooth ride. Still, this is Arcline’s preferred hunt—engineered components, defensible niches, and predictable bolt-on velocity. High-quality asset with operational upside still on the table. Deal strength: high-medium. Link

Investcorp Acquires Kanawha Scales & Systems

Investcorp is acquiring Kanawha Scales & Systems (KSS) from American Equipment Holdings and Rotunda Capital Partners. KSS is a 70-year-old industrial-services outfit focused on calibration, maintenance, and repair for weighing systems—unglamorous but beautifully recurring. The price wasn’t disclosed, but this is middle-market bread-and-butter: fragmented operators, mandated service cycles, and steady industrial end-markets. Investcorp will try to modernize the tech stack, tighten routing and utilization, and roll up smaller local competitors. It’s not a moonshot—more like buying a dependable cash-flow engine and tuning it for efficiency. Deal strength: moderate. Link

News (w/e 1/9/26)

Eir Partners Closes $1 Billion Fund Focused on Healthcare Technology Miami-based Eir Partners closed its third fund at $1 billion, blowing past its $800 million target in just a few months. The raise reinforces a clear LP preference: specialist healthcare investors with repeatable playbooks still get paid attention, even as

Deals (w/e 1/9/26)

Veritas Capital Buys Majority Stake in Global Healthcare ExchangeVeritas Capital is acquiring a majority stake in Global Healthcare Exchange (GHX), the healthcare supply-chain software platform used by hospitals and suppliers across the U.S. GHX sits in the unglamorous but essential plumbing of healthcare, where scale and data matter more

Private equity has quietly entered a new sport: competitive talent hoarding.

Every firm now appears to be stockpiling operators the way children collected Pokémon cards. Operating Partners, Senior Advisors, Venture Partners, EIRs—hand out a title, add them to a slide, declare victory. LPs love the imagery. It signals “capability.” It looks sophisticated. It gives the impression of a tightly coordinated

AI isn’t coming for middle management. It’s already rearranging the job description.

The layer of people whose primary function is aggregating information, writing summaries, building decks, and “managing up” is about to feel the shift first. Not because AI is more insightful than they are, but because it’s cheaper, faster, and doesn’t need three pre-meetings to prepare for the meeting.